Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1998-3-13
pubmed:abstractText
Activation, anergy, and apoptosis are all possible outcomes of T cell receptor (TCR) engagement. The first leads to proliferation and effector function, whereas the others can lead to partial or complete immunological tolerance. Structural variants of immunizing peptide-major histocompatibility complex molecule ligands that induce selective lymphokine secretion or anergy in mature T cells in association with altered intracellular signaling events have been described. Here we describe altered ligands for mature mouse CD4(+) T helper 1 cells that lead to T cell apoptosis by the selective expression of Fas ligand (FasL) and tumor necrosis factor (TNF) without concomitant IL-2, IL-3, or interferon gamma production. All ligands that stimulated cell death were found to induce FasL and TNF mRNA expression and TCR aggregation ("capping") at the cell surface, but did not elicit a common pattern of tyrosine phosphorylation of the TCR-associated signal transduction chains. Thus, TCR ligands that uniquely trigger T cell apoptosis without inducing cytokines that are normally associated with activation can be identified.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-1309938, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-1944559, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-2956608, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-6193170, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-7509084, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-7522230, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-7530335, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-7530336, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-7530337, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-7566090, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-7600296, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-7824949, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-8001128, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-8305133, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-8325332, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-8358789, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-8637599, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-8666771, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-8691128, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-8758894, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-8789425, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-8920243, http://linkedlifedata.com/resource/pubmed/commentcorrection/9449715-9106302
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome c Group, http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/Fas Ligand Protein, http://linkedlifedata.com/resource/pubmed/chemical/Fasl protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II, http://linkedlifedata.com/resource/pubmed/chemical/I-E-antigen, http://linkedlifedata.com/resource/pubmed/chemical/Ligands, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Phosphotyrosine, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
2
pubmed:volume
187
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
349-55
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:9449715-Amino Acid Sequence, pubmed-meshheading:9449715-Animals, pubmed-meshheading:9449715-Apoptosis, pubmed-meshheading:9449715-CD4-Positive T-Lymphocytes, pubmed-meshheading:9449715-Columbidae, pubmed-meshheading:9449715-Cytochrome c Group, pubmed-meshheading:9449715-Cytokines, pubmed-meshheading:9449715-Fas Ligand Protein, pubmed-meshheading:9449715-Gene Expression Regulation, pubmed-meshheading:9449715-Histocompatibility Antigens Class II, pubmed-meshheading:9449715-Ligands, pubmed-meshheading:9449715-Membrane Glycoproteins, pubmed-meshheading:9449715-Mice, pubmed-meshheading:9449715-Mice, Inbred Strains, pubmed-meshheading:9449715-Microscopy, Fluorescence, pubmed-meshheading:9449715-Molecular Sequence Data, pubmed-meshheading:9449715-Peptide Fragments, pubmed-meshheading:9449715-Phosphotyrosine, pubmed-meshheading:9449715-RNA, Messenger, pubmed-meshheading:9449715-Receptors, Antigen, T-Cell, pubmed-meshheading:9449715-T-Lymphocytes, Helper-Inducer, pubmed-meshheading:9449715-Tumor Necrosis Factor-alpha
pubmed:year
1998
pubmed:articleTitle
Selective induction of apoptosis in mature T lymphocytes by variant T cell receptor ligands.
pubmed:affiliation
Molecular Development of the Immune System Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
pubmed:publicationType
Journal Article